Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer

Intestinal perforation is a rare adverse event of antineoplastic therapy. However, once it occurs, it is potentially fatal. This report describes a case of intestinal perforation caused by bevacizumab in a patient with ovarian cancer who concurrently developed neutropenic enterocolitis. A 66-year-ol...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Akinori, Harano, Kenichi, Kogawa, Takahiro, Matsubara, Nobuaki, Naito, Yoichi, Hosono, Ako, Mukai, Hirofumi, Yoshino, Takayuki, Mukohara, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317333/
https://www.ncbi.nlm.nih.gov/pubmed/32612862
http://dx.doi.org/10.1155/2020/7231358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317333/
https://www.ncbi.nlm.nih.gov/pubmed/32612862
http://dx.doi.org/10.1155/2020/7231358

Ejemplares similares